Back to Search
Start Over
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial - Authors' reply.
- Source :
-
Lancet (London, England) [Lancet] 2024 Aug 03; Vol. 404 (10451), pp. 434. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1474-547X
- Volume :
- 404
- Issue :
- 10451
- Database :
- MEDLINE
- Journal :
- Lancet (London, England)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39097394
- Full Text :
- https://doi.org/10.1016/S0140-6736(24)01263-7